Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
CRON
Cronos Group
$1.98
Chart
1.81
1.97
1.95
2.64
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
CRON
Cronos Group
$1.98
Chart
1.81
1.97
1.95
2.64
CRON Latest Headlines
This Week In Cannabis: Earnings Divide The Market As DEA Brands And Bills Move Forward. The cannabis industry just wrapped one of the busiest earnings weeks of the quarter with more than ten companies reporting financials—including Curaleaf GTI Trulieve Verano Cronos Group and IIPR. The results revealed a widening gulf between United States plant-touching operators and asset-light or international players sparking mixed reactions across capital markets. Meanwhile headlines from Washington Missou
Fri May 9, 2025
Cronos stock rises after Q1 revenue beat.
Thu May 8, 2025
Cronos signals capacity expansion and record growth in Israel for 2025.
Thu May 8, 2025
Cannabis Earnings Show Market Split: US Plant-Touching Stocks Drop IIPR And Cronos Up. Between Wednesday afternoon and Thursday morning a slate of major cannabis companies reported their first quarter 2025 financial results. These included ) (OTCQX:) ) CBSTF) ) (OTCQX:) ) (TSX:) and ).Despite operational improvements and strategic progress across the board public market reactions revealed a split: United States-based plant-touching operators like GTI Verano Cannabist and MariMed all traded lower
Thu May 8, 2025
Cronos Stock Surges On Q1 Earnings Beat Strong Demand For Flower Products: 2025 Is Shaping Up To Be A Transformative Year. ) reported first-quarter financial results ahead of the market open Thursday. Here’.s a look at the key highlights from the cannabis company’.s report.estimates of $31.70 million according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share beating estimates for a loss of 1 cent per share.Cronos said first-quarter revenue increased 28%
Thu May 8, 2025
Cronos Group GAAP EPS of $0.02 revenue of $32.26M beats by $0.37M.
Thu May 8, 2025
Cronos Group Reports 2025 First Quarter Results. Net revenue in Q1 2025 increased by 28% year-over-year 33% year-over-year net revenue growth on a constant currency basis
Thu May 8, 2025
Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8 2025. ) (TSX:) (Cronos or the Company) will hold its 2025 first quarter earnings conference call on Thursday May 8 2025 at 8:30 a.m. ET. Cronos'. senior management team will discuss the Company'.s financial results and will be available for questions from the investment community after prepared remarks.. To avoid delays we encourage participants to dial into the conference call fifteen minutes ahead of the sch
Thu Apr 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRON Stock trends
CRON Stock performance
CRON Stock analysis
CRON investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Cronos Group (CRON) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
